Polymorphisms in hOGG1 and XRCC1 and Risk of Prostate Cancer

Effects Modified by Plasma Antioxidants

Jianjun Zhang , Ishwori B. Dhakal, Graham Greene, Nicholas P. Lang, Fred F. Kadlubar

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Objectives: To investigate whether polymorphisms in genes involved in the repair of oxidative DNA damage, modulate, and/or interact with antioxidants to influence prostate cancer risk in a population-based case-control study in Central Arkansas. Accumulating evidence indicates that oxidative stress plays a role in prostate carcinogenesis. Methods: Cases (n = 193) included men aged 40-80 years, diagnosed with prostate cancer in 3 major hospitals in 1998-2003, and controls (n = 197) were matched to cases by age, race, and county of residence. Results: After adjustment for confounders, subjects who were heterozygous or homozygous for the variant allele of the hOGG1 Ser326Cys polymorphism appeared to experience a lower risk of prostate cancer than those who were homozygous for the wild-type allele (odds ratio [OR] (95% confidence interval [CI]): 0.72 (0.46-1.10)]. Conversely, a significant increased risk was observed for individuals who carried 1 or 2 copies of the variant allele of the XRCC1 Arg399Gln polymorphism, compared with those who only harbored the wild-type allele (OR [95% CI]: 1.56 [1.01-2.45]). The above-mentioned associations were generally more pronounced among subjects with low plasma carotenoids or α-tocopherol (<median). Among subjects who had low plasma levels of β-cryptoxanthin (<73 μg/L), possession of at least 1 copy of the XRCC1 399Gln allele conferred a greater than 2-fold elevated risk (OR [95% CI]: 2.64 [1.40-5.07]). Conclusions: Our study offers preliminary but intriguing data suggesting that variability in the capacity of repairing oxidative DNA damage influences susceptibility to prostate cancer and that these effects are modified by antioxidants.

Original languageEnglish
Pages (from-to)779-785
Number of pages7
JournalUrology
Volume75
Issue number4
DOIs
StatePublished - Apr 2010

Fingerprint

Prostatic Neoplasms
Antioxidants
Alleles
Odds Ratio
Confidence Intervals
DNA Damage
Tocopherols
Carotenoids
Case-Control Studies
Prostate
Carcinogenesis
Oxidative Stress
Population
Genes

ASJC Scopus subject areas

  • Urology

Cite this

Polymorphisms in hOGG1 and XRCC1 and Risk of Prostate Cancer : Effects Modified by Plasma Antioxidants. / Zhang , Jianjun; Dhakal, Ishwori B.; Greene, Graham; Lang, Nicholas P.; Kadlubar, Fred F.

In: Urology, Vol. 75, No. 4, 04.2010, p. 779-785.

Research output: Contribution to journalArticle

Zhang , Jianjun ; Dhakal, Ishwori B. ; Greene, Graham ; Lang, Nicholas P. ; Kadlubar, Fred F. / Polymorphisms in hOGG1 and XRCC1 and Risk of Prostate Cancer : Effects Modified by Plasma Antioxidants. In: Urology. 2010 ; Vol. 75, No. 4. pp. 779-785.
@article{7bdcb5777fcf4a6fb43392bea8a2d213,
title = "Polymorphisms in hOGG1 and XRCC1 and Risk of Prostate Cancer: Effects Modified by Plasma Antioxidants",
abstract = "Objectives: To investigate whether polymorphisms in genes involved in the repair of oxidative DNA damage, modulate, and/or interact with antioxidants to influence prostate cancer risk in a population-based case-control study in Central Arkansas. Accumulating evidence indicates that oxidative stress plays a role in prostate carcinogenesis. Methods: Cases (n = 193) included men aged 40-80 years, diagnosed with prostate cancer in 3 major hospitals in 1998-2003, and controls (n = 197) were matched to cases by age, race, and county of residence. Results: After adjustment for confounders, subjects who were heterozygous or homozygous for the variant allele of the hOGG1 Ser326Cys polymorphism appeared to experience a lower risk of prostate cancer than those who were homozygous for the wild-type allele (odds ratio [OR] (95{\%} confidence interval [CI]): 0.72 (0.46-1.10)]. Conversely, a significant increased risk was observed for individuals who carried 1 or 2 copies of the variant allele of the XRCC1 Arg399Gln polymorphism, compared with those who only harbored the wild-type allele (OR [95{\%} CI]: 1.56 [1.01-2.45]). The above-mentioned associations were generally more pronounced among subjects with low plasma carotenoids or α-tocopherol (",
author = "Jianjun Zhang  and Dhakal, {Ishwori B.} and Graham Greene and Lang, {Nicholas P.} and Kadlubar, {Fred F.}",
year = "2010",
month = "4",
doi = "10.1016/j.urology.2009.08.063",
language = "English",
volume = "75",
pages = "779--785",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Polymorphisms in hOGG1 and XRCC1 and Risk of Prostate Cancer

T2 - Effects Modified by Plasma Antioxidants

AU - Zhang , Jianjun

AU - Dhakal, Ishwori B.

AU - Greene, Graham

AU - Lang, Nicholas P.

AU - Kadlubar, Fred F.

PY - 2010/4

Y1 - 2010/4

N2 - Objectives: To investigate whether polymorphisms in genes involved in the repair of oxidative DNA damage, modulate, and/or interact with antioxidants to influence prostate cancer risk in a population-based case-control study in Central Arkansas. Accumulating evidence indicates that oxidative stress plays a role in prostate carcinogenesis. Methods: Cases (n = 193) included men aged 40-80 years, diagnosed with prostate cancer in 3 major hospitals in 1998-2003, and controls (n = 197) were matched to cases by age, race, and county of residence. Results: After adjustment for confounders, subjects who were heterozygous or homozygous for the variant allele of the hOGG1 Ser326Cys polymorphism appeared to experience a lower risk of prostate cancer than those who were homozygous for the wild-type allele (odds ratio [OR] (95% confidence interval [CI]): 0.72 (0.46-1.10)]. Conversely, a significant increased risk was observed for individuals who carried 1 or 2 copies of the variant allele of the XRCC1 Arg399Gln polymorphism, compared with those who only harbored the wild-type allele (OR [95% CI]: 1.56 [1.01-2.45]). The above-mentioned associations were generally more pronounced among subjects with low plasma carotenoids or α-tocopherol (

AB - Objectives: To investigate whether polymorphisms in genes involved in the repair of oxidative DNA damage, modulate, and/or interact with antioxidants to influence prostate cancer risk in a population-based case-control study in Central Arkansas. Accumulating evidence indicates that oxidative stress plays a role in prostate carcinogenesis. Methods: Cases (n = 193) included men aged 40-80 years, diagnosed with prostate cancer in 3 major hospitals in 1998-2003, and controls (n = 197) were matched to cases by age, race, and county of residence. Results: After adjustment for confounders, subjects who were heterozygous or homozygous for the variant allele of the hOGG1 Ser326Cys polymorphism appeared to experience a lower risk of prostate cancer than those who were homozygous for the wild-type allele (odds ratio [OR] (95% confidence interval [CI]): 0.72 (0.46-1.10)]. Conversely, a significant increased risk was observed for individuals who carried 1 or 2 copies of the variant allele of the XRCC1 Arg399Gln polymorphism, compared with those who only harbored the wild-type allele (OR [95% CI]: 1.56 [1.01-2.45]). The above-mentioned associations were generally more pronounced among subjects with low plasma carotenoids or α-tocopherol (

UR - http://www.scopus.com/inward/record.url?scp=77950298611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950298611&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2009.08.063

DO - 10.1016/j.urology.2009.08.063

M3 - Article

VL - 75

SP - 779

EP - 785

JO - Urology

JF - Urology

SN - 0090-4295

IS - 4

ER -